TSOMORLOG AUSTIN: Open Payments
NPI 1184338147 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 49 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,206 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $462 |
| GlaxoSmithKline, LLC. | 19 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Genentech USA, Inc. | 2 | $46 |
| GENZYME CORPORATION | 2 | $46 |
| Amgen Inc. | 1 | $24 |
| Grifols USA, LLC | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
Products named: TEZSPIRE, TRELEGY ELLIPTA, NUCALA, DUPIXENT, FASENRA, Xolair, CUVITRU, AIRSUPRA.
Industry payments across CO — which companies pay providers there.
